Union Seeks $3.5 Billion Savings by Cutting Insurers From Medicaid Home Care System

New York’s home care funding debate lays bare the tension between public thrift and private efficiency in social services.

Few New York numbers are as eye-watering as the $30 billion the state shovels annually into its gargantuan Medicaid programme. Of that sum, billions are funneled, circuitously, through private insurers tasked with coordinating and paying for home care. Now, a resurgent union-led campaign argues that these middlemen are a costly indulgence the Empire State can ill afford.

On a cloud-scudded Monday outside City Hall, hundreds of members of 1199SEIU Healthcare Workers East, the region’s largest health-sector union, rallied in support of the Home Care Savings and Reinvestment Act (HCSRA), a bill they say could lop some $3.5 billion per year off the state’s administrative outlay for home care. The mechanism is straightforward, if procedurally ambitious: it would excise commercial insurance companies from the home care payment apparatus, shifting the responsibility for care coordination and provider payment to the state itself—through a managed fee-for-service system.

This is not a wholly novel idea. New York, like most American states, began farming out long-term Medicaid services to managed care insurers over a decade ago, lured by the promise of tauter oversight and healthier public finances. The hope: private sector discipline would stanch the steady increases in spending for services like home health aides and the popular Consumer Directed Personal Assistance Program (CDPAP). Instead, critics allege, administrative bloat and opacity have drained public coffers while leaving care quality unimproved.

Helen Schaub, 1199SEIU’s flinty political director, contends that the privatized approach “has demonstrably failed.” She and her allies accuse insurers of cherry-picking healthier, lower-cost enrollees (thereby plumping profits) while layering the system with duplicative bureaucracy. Enrollment in managed long-term care plans has soared, with Medicaid’s home care bill in New York swelling in tandem.

The HCSRA’s sponsors, led by State Senator Gustavo Rivera and Assemblywoman Amy Paulin, reckon the timing is auspicious. Federal Medicaid matching rates are slated to tighten, and New York faces daunting budgetary headwinds. Should the legislation pass and be implemented—likely a matter of years, not months—even conservative estimates hold that net annual savings could eclipse $1.7 billion, once new state administrative costs (projected at $1.8 billion a year) are factored in.

Yet not all view this arithmetic so benignly. The New York Health Plan Association, representing the ousted insurers, argues the transition would be anything but painless. Eric Linzer, its president, warns of system “disruption”—affecting care for 285,000 elderly and disabled New Yorkers dependent on managed long-term care. He contends shifting to direct state management risks reducing consumer choice and could expose the state to fresh inefficiencies.

For New York City, always the sine qua non of statewide Medicaid spending, the stakes are anything but abstract. The city accounts for a lion’s share of the state’s low-income Medicaid beneficiaries and thus the costliest home care cases. A streamlined system might, in theory, ensure scarcer resources flow to actual services rather than insurance administration. It might also afford City Hall more fiscal breathing room as it juggles post-pandemic recovery and stubborn poverty rates.

In the first order, if the estimates from 1199SEIU and its legislative allies bear out, the move could allow lucrative reinvestment into home care wages, quality-of-life improvements for patients, or even offsetting property tax hikes. Still, the prospect of upheaval for nearly 300,000 of the city and state’s most vulnerable residents is hardly trifling. Changing payment and care coordination systems can be a bureaucratic quagmire, prone to teething problems that have hobbled even smaller-scale reforms.

Second-order effects loom larger still. Medicaid is both social glue and economic engine in Gotham; its wage floors and reimbursement rates shape an entire sector’s labour market. If savings materialize, the city might see a modest reduction in the Sisyphean pressure to raise local taxes or cut elsewhere. But should service disruption ensue—delayed payments to agencies, missed home visits, management snafus—the political blowback would be swift and bracing.

Broader comparisons do not flatter New York’s system. Across the Atlantic, the British NHS runs its social care with state payrolls—and complaints of bureaucracy and delays. Other American states, notably California, have tinkered with similar reforms, often finding that centralized management introduces its own thicket of inefficiency and overwork for public staff. Yet with America’s ageing population and long-term care spending forecast to balloon further, the status quo is scarcely bulletproof.

Who moves the needle in Medicaid reform?

New York’s Medicaid journey echoes national cross-currents: a cyclical disenchantment with both pure government solutions and pure market delivery. The insurance lobby’s warnings of “disruption” are not without historical precedent—transitions in complex systems regularly knot up, at least initially. Union promises of billions in savings may prove optimistic when tested by the chronic friction and inertia of state bureaucracies.

We take a sceptically optimistic view. The impulse to weed out waste and recapture public value from an insurance layer that has not delivered persistent savings is laudable. Transparency and tighter control may, in this case, bring the dull but necessary virtue of thrift. Yet the switch from managed care is not a panacea. The state bureaucracy, already groaning under existing mandates, could find itself overwhelmed; private payers, for all their fees, sometimes show more agility in rooting out fraud or swiftly addressing care needs.

Public expectations should be tempered. A nimble Manhattan startup the Health Department is not. Meaningful reform, whether of payment flow or care standards, will require robust oversight and willingness to correct course quickly—a commodity too often lacking in Albany policymaking. Still, wrestling Medicaid costs into a more sustainable shape is a worthy, if Sisyphean, enterprise.

The broader lesson is that when it comes to fiscal discipline, New York’s history of toggling between public and private solutions offers little encouragement. What matters, ultimately, is not the machinery but the results: care that is affordable, accessible, and as free from administration-induced headaches as possible. On that measure, both union agitators and insurance magnates will need to wait and watch—perhaps grimly—as the city’s latest experiment plays out. ■